Previous Page  11 / 30 Next Page
Information
Show Menu
Previous Page 11 / 30 Next Page
Page Background

Minimal Residual Disease

Monitoring Tumor Burden

Biomarkers of sensitivity to

treatments

Biomarkers of resistance to

treatments

A comprehensive panel is required for many applications: NGS based

T

N

Gene-panel

capture

approaches (up

to 24000 genes)

Exome-seq

(24000 genes)

Whole genome

sequencing

Amplicon-seq

(up to 200

genes)